COMMUNIQUÉS West-GlobeNewswire

Solon Eiendom ASA – Primary insider notification

07/09/2018 - 08:30

(Oslo, Norway, September 6, 2018) Solon Eiendom ASA Board Member Tore Aksel Voldberg has today through his wholly owned company Dukat AS bought 15.000 shares in Solon Eiendom ASA at a price of NOK 28.1659. Following [...]

Oasmia completes a private placement of new convertible instruments in the amount SEK 35.2 million

07/09/2018 - 08:30

Oasmia Pharmaceutical AB (publ) (“Oasmia” or the “Company”) hereby announces that the Company has completed a private placement of a convertible loan in the total amount of SEK 35,200,000 with an interest rate of 8 per [...]

DBV Technologies : Reports First Half 2018 Financial Results

07/09/2018 - 07:31

Montrouge, France, September 7, 2018 DBV Technologies Reports First Half 2018 Financial Results DBV Technologies (Euronext: DBV - ISIN: FR0010417345 - Nasdaq Stock Market: DBVT), a clinical-stage biopharmaceutical [...]

DBV Technologies : Résultats financiers du premier semestre 2018

07/09/2018 - 07:31

Montrouge, France, le 7 septembre 2018 (7H30 CEST) DBV Technologies résultats financiers du premier semestre 2018 DBV Technologies (Euronext: DBV - ISIN : FR0010417345 - NASDAQ : DBVT), société biopharmaceutique [...]

Pediapharm Announces Transformative Acquisitions and $60 Million Offering of Subscription Receipts

07/09/2018 - 02:29

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF UNITED STATES SECURITIES LAW. MONTREAL, Sept. 06, [...]

Clearside Biomedical Further Strengthens Commercial Organization With Appointment of Lester Rodríguez as Vice President, Quality

06/09/2018 - 22:30

ALPHARETTA, Ga., Sept. 06, 2018 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (NASDAQ: CLSD), a biopharmaceutical company dedicated to developing treatments that restore and preserve vision for people with serious eye [...]

Neon Therapeutics to Present at Morgan Stanley 16th Annual Global Healthcare Conference

06/09/2018 - 22:15

CAMBRIDGE, Mass., Sept. 06, 2018 (GLOBE NEWSWIRE) -- Neon Therapeutics, Inc. (Nasdaq: NTGN), a clinical-stage immuno-oncology company developing neoantigen-based therapeutics, today announced that management will [...]

Radius Health Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

06/09/2018 - 22:15

WALTHAM, Mass., Sept. 06, 2018 (GLOBE NEWSWIRE) -- Radius Health, Inc. (“Radius” or the “Company”) (Nasdaq:RDUS) today announced that the Company’s Board of Directors granted Dr. Charles Morris, in connection with his [...]

Profound Medical Files Preliminary Base Shelf Prospectus

06/09/2018 - 22:10

NOT FOR DISTRIBUTION IN THE UNITED STATES OR OVER UNITED STATES WIRE SERVICES TORONTO, Sept. 06, 2018 (GLOBE NEWSWIRE) -- Profound Medical Corp. (TSX:PRN; OTCQX:PRFMF) (“Profound” or the “Company”) announced today that [...]

Zealand sells royalty streams and milestones for USD 205 million to Royalty Pharma

06/09/2018 - 22:05

Company announcement - No. 21/ 2018 Zealand sells royalty streams and milestones for USD 205 million to Royalty Pharma Copenhagen, September 6, 2018 - Zealand Pharma A/S ("Zealand") (NASDAQ: ZEAL), a Copenhagen-based [...]

IRIDEX Announces FDA Clearance to Introduce Updated TruFocus LIO Premiere™ Laser Accessory to the U.S. Market

06/09/2018 - 22:05

MOUNTAIN VIEW, Calif., Sept. 06, 2018 (GLOBE NEWSWIRE) -- IRIDEX Corporation (Nasdaq: IRIX) today announced the introduction of its updated TruFocus LIO Premiere™ laser accessory following U.S. Food and Drug [...]

GBT Announces New Employment Inducement Grants

06/09/2018 - 22:05

SOUTH SAN FRANCISCO, Calif., Sept. 06, 2018 (GLOBE NEWSWIRE) -- Global Blood Therapeutics, Inc. (GBT) (NASDAQ: GBT) today announced that, on September 4, 2018, the compensation committee of the Company’s board of [...]

Institutional Shareholder Services (ISS), Leading Proxy Advisor, Recommends Medigus Shareholders Vote “FOR” all Medigus’ Director Nominees

06/09/2018 - 22:05

-Medigus Implores Stockholders to Protect the Value of Their Investment and Vote “FOR” Medigus’ Director Nominees on the WHITE Proxy Card- OMER, Israel, Sept. 06, 2018 (GLOBE NEWSWIRE) -- Medigus Ltd. (“Medigus” or the [...]

Ascendis Pharma A/S Announces Presentations on Technology and Rare Disease Endocrinology Pipeline at September Conferences

06/09/2018 - 22:02

COPENHAGEN, Denmark, Sept. 06, 2018 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND), a biopharmaceutical company that utilizes its innovative TransCon™ technology to address significant unmet medical needs, today [...]

Replimune Announces FDA Acceptance of Investigational New Drug Application for its Lead Oncolytic Immunotherapy Candidate, RP1

06/09/2018 - 22:01

WOBURN, Mass., Sept. 06, 2018 (GLOBE NEWSWIRE) -- Replimune Group Inc. (NASDAQ: REPL), a biotechnology company developing oncolytic immunotherapies derived from its Immulytic™ platform, today announced the U.S. Food and [...]

Supernus Wins Appeal on Oxtellar XR® against TWi

06/09/2018 - 21:34

Second Appeal Win against Generic Filers ROCKVILLE, Md., Sept. 06, 2018 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (NASDAQ: SUPN), a pharmaceutical company focused on developing and commercializing products for [...]

CORRECTING and REPLACING - Misonix Reports Record Fourth Quarter and Fiscal Year 2018 Revenue

06/09/2018 - 19:40

Fiscal Year 2018 Revenue Rises 35% to $36.7 Million FARMINGDALE, N.Y., Sept. 06, 2018 (GLOBE NEWSWIRE) -- On September 5, 2018, Misonix, Inc. (Nasdaq: MSON) (“Misonix” or the “Company”), issued a press release [...]

Orion Biotechnology acquires patent portfolio for potent CCR5 chemokine antagonist

06/09/2018 - 19:08

OTTAWA, Sept. 06, 2018 (GLOBE NEWSWIRE) -- Orion Biotechnology Canada Ltd., a developer of novel medical treatments, today announced that its subsidiary, Orion Biotechnology Switzerland Sàrl, has successfully closed a [...]

VALNEVA : Déclaration d'actions et de droits de vote Août 2018

06/09/2018 - 18:31

VALNEVA Déclaration d'actions et de droits de vote - AOUT 2018 Dénomination sociale : VALNEVA Adresse du siège social : 6 rue Alain Bombard, 44800 Saint-Herblain Marché réglementé Euronext Paris de Nyse Euronext - [...]